SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 916,153 | $8,740,000 | 1.27% |
| Casdin Capital, LLC | 1,080,000 | $10,303,000 | 1.13% |
| Rhenman & Partners Asset Management AB | 843,957 | $8,051,000 | 0.94% |
| WASATCH ADVISORS LP | 6,437,908 | $61,418,000 | 0.67% |
| BB BIOTECH AG | 2,650,000 | $25,281,000 | 0.64% |
| Trellus Management Company, LLC | 30,000 | $286,000 | 0.54% |
| Opus Point Partners Management, LLC | 33,529 | $320,000 | 0.43% |
| SECTOR GAMMA AS | 238,857 | $2,279,000 | 0.36% |
| Leisure Capital Management | 37,656 | $359,000 | 0.30% |
| Ceeto Capital Group, LLC | 41,000 | $391,000 | 0.29% |